BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Japan

Asahi Kasei to Build New Planova™ Virus Filter Plant in Japan to Meet Surging Biopharma Demand

Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova&trad...

July 31, 2025 | News

Tigermed Acquires Japan’s First Imaging CRO Micron to Bolster Asia-Pacific Medical Imaging Capabilities

Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, annou...

July 30, 2025 | News

Revival Healthcare Capital and Olympus Launch $458M Joint Venture to Advance GI Robotics Innovation

Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships in MedTech is, pleased to announce a st...

July 28, 2025 | News

GHIT Fund Commits JPY 1 Billion to Combat Malaria and Tuberculosis Through Global R&D Partnerships

The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1 billion (USD 7.3 million1) in ...

July 17, 2025 | News

Japanese Life Sciences Delegation Strengthens Collaboration with North Carolina’s Innovation Ecosystem

A high-level Japanese delegation specializing in life sciences concluded a three-day visit to North Carolina (June 24–26), further strengthening ties...

July 07, 2025 | News

AvenCell Secures Up to $40 Million AMED Grant to Advance Dual-Antigen Allogeneic CAR-T Therapy

AvenCell Japan, a wholly owned subsidiary of AvenCell Therapeutics, a private, clinical-stage biotechnology company developing best-in-class CAR-T therapie...

July 02, 2025 | News

Alpha Fusion and Curadh Forge Joint Venture to Advance Astatine-211 Radiopharmaceuticals Globally

Alpha Fusion, Inc. ("Alpha Fusion") and Curadh MTR Inc. ("Curadh") announced plans to enter a strategic partnership, including a Joint Venture t...

July 01, 2025 | News

AGC Biologics Launches Cell Therapy Manufacturing Services in Yokohama to Expand Global CDMO Footprint

AGC Biologics, your friendly CDMO expert, will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC Inc....

June 26, 2025 | News

Daiichi Sankyo and AstraZeneca’s DATROWAY Receives U.S. FDA Accelerated Approval for EGFR-Mutated Lung Cancer

Based on TROPION-Lung05 phase 2 trial results and supported by data from the TROPION-Lung01 phase 3 trial Second U.S. approval for Daiichi Sankyo and ...

June 24, 2025 | News

MedHub-AI Secures PMDA Approval in Japan for AutocathFFR®, the World’s First Fully Automated AI-Driven FFR Solution

MedHub-AI, a global leader in AI-powered cardiovascular diagnostics, announced today that the Pharmaceuticals and Medical Devices Agency (PMDA) in&nb...

June 19, 2025 | News

NEC and Chugai Harness AI to Halve Time Needed for Predicting Effective Cancer Drug Combinations

Identified the potential to reduce the time required to research and predict drug combinations by approximately 50% NEC Corporation (NEC; TSE: ...

June 19, 2025 | News

Hoth Therapeutics Secures Japan Patent for HT-KIT Splice-Switching Platform Targeting Mast Cell Disorders

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies, today announced that they have obtained...

June 13, 2025 | News

Samsung Bioepis Partners with NIPRO to Expand Biosimilar Access in Japan

Samsung Bioepis expands its presence in Japanese market through partnership with NIPRO Corporation Marks a step forward in widening treatments options a...

June 09, 2025 | News

FUJIFILM Unifies Life Sciences Brands to Deliver End-to-End Drug Development Solutions

FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences, providing a full spectrum of life sciences solutions built from a 55-year history as a c...

June 04, 2025 | News

Stay Connected